Beijing Bio-Targeting Therapeutics Technology Inc.

Chine

 
Quantité totale PI 8
Rang # Quantité totale PI 193 666
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 470 185

Brevets

Marques

5 0
0 0
3 0
0
 
Dernier brevet 2022 - Modified interleukin 12 and use ...
Premier brevet 2012 - Oncolytic adenovirus for target ...

Derniers inventions, produits et services

2022 Invention Modified interleukin 12 and use thereof in preparing drugs for treating tumours. The present inv...
2018 Invention Subgroup b recombinant human adenovirus vector, and methods for constructing and for using the sa...
2016 Invention Modified interleukin 12 and use thereof in preparing drugs for treating tumours. The present inve...
Invention Modified interleukin 12 and use thereof in preparing drugs for treating tumours. Provided are a m...
2013 Invention Targeted oncolytic adenovirus for treatment of human tumors, constrcution method and application ...
2012 Invention Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic pow...
Invention Oncolytic adenovirus for target therapy of human tumor and use thereof. Provided is an oncolytic ...